We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
+10.07%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$419M
AUM Growth
+$148M
(+54%)
Cap. Flow
+$129M
Cap. Flow
% of AUM
30.92%
Top 10 Holdings %
Top 10 Hldgs %
12.65%
Holding
735
New
336
Increased
76
Reduced
46
Closed
277
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$6.95M |
| 2 |
Apple
AAPL
|
+$6.94M |
| 3 |
COL
Rockwell Collins
COL
|
+$5.18M |
| 4 |
Carnival Corporation Ltd
CCL
|
+$5.04M |
| 5 |
Molson Coors Class B
TAP
|
+$4.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$9.64M |
| 2 |
Acuity Brands
AYI
|
+$4.57M |
| 3 |
Mondelez International
MDLZ
|
+$3.38M |
| 4 |
Costco
COST
|
+$2.98M |
| 5 |
Intuit
INTU
|
+$2.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.55% |
| 2 | Consumer Discretionary | 17.53% |
| 3 | Healthcare | 13.84% |
| 4 | Industrials | 10.3% |
| 5 | Consumer Staples | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Corcept Therapeutics
CORT
$9.78B
| $284K | 0.07% |
+14,700
| New | +$219K |
|
|
ENV
377
DELISTED
ENVESTNET, INC.
ENV
| $282K | 0.07% |
+5,524
| New | +$236K |
|
|
EBIX
378
DELISTED
Ebix Inc
EBIX
| $281K | 0.07% |
+4,300
| New | +$248K |
|
|
SAGE
379
DELISTED
Sage Therapeutics
SAGE
| $280K | 0.07% |
+4,492
| New | +$353K |
|
|
WCN
380
Waste Connections
WCN
$42.7B
| $280K | 0.07% |
4,000
-4,800
| -55% | -$317K |
|
381
Camden Property Trust
CPT
$11.2B
| $279K | 0.07% |
+3,048
| New | +$274K |
|
382
Ryder
R
$10.3B
| $279K | 0.07% |
+3,300
| New | +$250K |
|
383
Williams Companies
WMB
$86.6B
| $279K | 0.07% |
+9,300
| New | +$283K |
|
|
EPAY
384
DELISTED
Bottomline Technologies Inc
EPAY
| $275K | 0.07% |
+8,625
| New | +$251K |
|
385
Neurocrine Biosciences
NBIX
$17.7B
| $274K | 0.07% |
+4,466
| New | +$236K |
|
386
Waste Management
WM
$95.5B
| $274K | 0.07% |
+3,500
| New | +$266K |
|
387
Rithm Capital
RITM
$5.15B
| $273K | 0.07% |
+16,300
| New | +$267K |
|
388
Qualys
QLYS
$4.75B
| $271K | 0.06% |
+5,238
| New | +$240K |
|
389
Kemper
KMPR
$1.73B
| $268K | 0.06% |
+5,066
| New | +$231K |
|
390
Mastercard
MA
$487B
| $268K | 0.06% |
1,900
-2,567
| -57% | -$340K |
|
|
XENT
391
DELISTED
Intersect ENT, Inc
XENT
| $267K | 0.06% |
+8,575
| New | +$254K |
|
|
CAVM
392
DELISTED
Cavium, Inc.
CAVM
| $260K | 0.06% |
+3,945
| New | +$250K |
|
|
PR
393
Permian Resources
PR
$17B
| $259K | 0.06% |
+14,400
| New | +$241K |
|
394
Cars.com
CARS
$660M
| $258K | 0.06% |
+9,690
| New | +$246K |
|
395
Duluth Holdings
DLTH
$162M
| $252K | 0.06% |
+12,400
| New | +$240K |
|
396
Skywest
SKYW
$4.37B
| $252K | 0.06% |
5,746
-1,100
| -16% | -$41.1K |
|
397
Huazhu Hotels Group
HTHT
$12.9B
| $251K | 0.06% |
+8,444
| New | +$219K |
|
398
United Rentals
URI
$70.2B
| $250K | 0.06% |
+1,800
| New | +$215K |
|
|
ICPT
399
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $250K | 0.06% |
4,300
+1,800
| +72% | +$194K |
|
400
Nice
NICE
$5.57B
| $243K | 0.06% |
+2,991
| New | +$232K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, Bayesian Capital Management held 735 positions worth $419M, up 54% from $271M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bayesian Capital Management deployed $129M of net new capital in Q3 2017, opening 336 new positions and adding to 76 existing holdings. Its largest new stake was Accenture: 53,319 shares worth $7.2M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Vodafone, an estimated $1.72M trimmed.
- Bayesian Capital Management's largest Q3 2017 buy was Accenture: 53,319 shares worth $7.2M.
- Bayesian Capital Management added most to Rockwell Collins in Q3 2017, an estimated $5.18M increase.
- Bayesian Capital Management's biggest Q3 2017 reduction was Vodafone, cutting an estimated $1.72M.
- Bayesian Capital Management fully exited Nike in Q3 2017, selling an estimated $9.64M.
- Bayesian Capital Management's ten largest holdings make up 13% of its $419M portfolio in Q3 2017.
- Bayesian Capital Management opened 336 new positions and closed 277 in Q3 2017.
- Bayesian Capital Management's portfolio value rose 54% quarter-over-quarter to $419M.
Based on Bayesian Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.